Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.ACS Infectious Diseases|February 27, 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of Mycobacterium tuberculosisSimon R Green, Justin R Harrison, Stephen Thompson, et al.ACS Infectious Diseases|April 5, 2024
Inhibitors of the Thioesterase Activity of Mycobacterium tuberculosis Pks13 Discovered Using DNA-Encoded Chemical Library ScreeningInna V Krieger, Subbarao Yalamanchili, Paige Dickson, et al.Journal of Medicinal Chemistry|January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action StudiesCandice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.Journal of Medicinal Chemistry|August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of TuberculosisSusan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.Elife|February 3, 2022
Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse miceClare M Smith, Richard E Baker, Megan K Proulx, et al.Journal of Medicinal Chemistry|December 15, 2021
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical TargetCaroline Wilson, Peter Ray, Fabio Zuccotto, et al.ACS Omega|February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis GrowthPeter C Ray, Margaret Huggett, Penelope A Turner, et al.Nature|June 21, 2019
Large-scale chemical-genetics yields new M. tuberculosis inhibitor classesEachan O Johnson, Emily LaVerriere, Emma Office, et al.Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.Pageof 14